Logo image of KIN.BR

KINEPOLIS (KIN.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:KIN - BE0974274061 - Common Stock

29.45 EUR
-0.2 (-0.67%)
Last: 12/19/2025, 7:00:00 PM
Fundamental Rating

4

KIN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 49 industry peers in the Entertainment industry. While KIN is still in line with the averages on profitability rating, there are concerns on its financial health. KIN scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

KIN had positive earnings in the past year.
KIN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: KIN reported negative net income in multiple years.
KIN had a positive operating cash flow in 4 of the past 5 years.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

KIN has a better Return On Assets (4.54%) than 69.39% of its industry peers.
With an excellent Return On Equity value of 23.61%, KIN belongs to the best of the industry, outperforming 83.67% of the companies in the same industry.
The Return On Invested Capital of KIN (8.28%) is better than 73.47% of its industry peers.
KIN had an Average Return On Invested Capital over the past 3 years of 6.76%. This is below the industry average of 9.36%.
The 3 year average ROIC (6.76%) for KIN is below the current ROIC(8.28%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROIC 8.28%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

Looking at the Profit Margin, with a value of 7.98%, KIN is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
In the last couple of years the Profit Margin of KIN has declined.
KIN's Operating Margin of 15.19% is amongst the best of the industry. KIN outperforms 87.76% of its industry peers.
KIN's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 24.54%, KIN is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
KIN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

2

2. Health

2.1 Basic Checks

KIN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, KIN has about the same amount of shares outstanding.
The number of shares outstanding for KIN has been increased compared to 5 years ago.
Compared to 1 year ago, KIN has an improved debt to assets ratio.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

KIN has an Altman-Z score of 1.54. This is a bad value and indicates that KIN is not financially healthy and even has some risk of bankruptcy.
KIN's Altman-Z score of 1.54 is fine compared to the rest of the industry. KIN outperforms 63.27% of its industry peers.
KIN has a debt to FCF ratio of 5.38. This is a neutral value as KIN would need 5.38 years to pay back of all of its debts.
KIN has a Debt to FCF ratio (5.38) which is comparable to the rest of the industry.
A Debt/Equity ratio of 2.87 is on the high side and indicates that KIN has dependencies on debt financing.
The Debt to Equity ratio of KIN (2.87) is worse than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Altman-Z 1.54
ROIC/WACC1.48
WACC5.61%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.47 indicates that KIN may have some problems paying its short term obligations.
KIN has a Current ratio of 0.47. This is amonst the worse of the industry: KIN underperforms 89.80% of its industry peers.
A Quick Ratio of 0.44 indicates that KIN may have some problems paying its short term obligations.
KIN has a worse Quick ratio (0.44) than 89.80% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.44
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

KIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.32%, which is quite impressive.
KIN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.80% yearly.
Looking at the last year, KIN shows a small growth in Revenue. The Revenue has grown by 5.38% in the last year.
The Revenue has been growing slightly by 0.95% on average over the past years.
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%

3.2 Future

The Earnings Per Share is expected to grow by 14.94% on average over the next years. This is quite good.
KIN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.98% yearly.
EPS Next Y22.89%
EPS Next 2Y26.59%
EPS Next 3Y21.24%
EPS Next 5Y14.94%
Revenue Next Year3.49%
Revenue Next 2Y9.56%
Revenue Next 3Y7.85%
Revenue Next 5Y4.98%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.22, which indicates a rather expensive current valuation of KIN.
85.71% of the companies in the same industry are more expensive than KIN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.38, KIN is valued a bit cheaper.
The Price/Forward Earnings ratio is 10.96, which indicates a very decent valuation of KIN.
Based on the Price/Forward Earnings ratio, KIN is valued cheaply inside the industry as 81.63% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of KIN to the average of the S&P500 Index (23.83), we can say KIN is valued rather cheaply.
Industry RankSector Rank
PE 17.22
Fwd PE 10.96
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, KIN is valued a bit cheaper than the industry average as 65.31% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of KIN indicates a rather cheap valuation: KIN is cheaper than 83.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.17
EV/EBITDA 8.45
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as KIN's earnings are expected to grow with 21.24% in the coming years.
PEG (NY)0.75
PEG (5Y)N/A
EPS Next 2Y26.59%
EPS Next 3Y21.24%

3

5. Dividend

5.1 Amount

KIN has a Yearly Dividend Yield of 1.30%.
Compared to an average industry Dividend Yield of 0.88, KIN pays a bit more dividend than its industry peers.
KIN's Dividend Yield is slightly below the S&P500 average, which is at 1.87.
Industry RankSector Rank
Dividend Yield 1.3%

5.2 History

The dividend of KIN decreases each year by -3.32%.
Dividend Growth(5Y)-3.32%
Div Incr Years1
Div Non Decr Years2
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

KIN pays out 31.09% of its income as dividend. This is a sustainable payout ratio.
DP31.09%
EPS Next 2Y26.59%
EPS Next 3Y21.24%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

KINEPOLIS

EBR:KIN (12/19/2025, 7:00:00 PM)

29.45

-0.2 (-0.67%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-21 2025-08-21
Earnings (Next)02-20 2026-02-20/amc
Inst Owners17.66%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap806.05M
Revenue(TTM)593.29M
Net Income(TTM)47.32M
Analysts86
Price Target49.3 (67.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.3%
Yearly Dividend0.54
Dividend Growth(5Y)-3.32%
DP31.09%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.35%
PT rev (3m)-0.34%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.13%
EPS NY rev (3m)-10.6%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)-1.14%
Valuation
Industry RankSector Rank
PE 17.22
Fwd PE 10.96
P/S 1.36
P/FCF 6.17
P/OCF 4.65
P/B 4.02
P/tB 35.96
EV/EBITDA 8.45
EPS(TTM)1.71
EY5.81%
EPS(NY)2.69
Fwd EY9.12%
FCF(TTM)4.77
FCFY16.2%
OCF(TTM)6.34
OCFY21.52%
SpS21.68
BVpS7.32
TBVpS0.82
PEG (NY)0.75
PEG (5Y)N/A
Graham Number16.79
Profitability
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROCE 11.27%
ROIC 8.28%
ROICexc 8.93%
ROICexgc 11.76%
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
FCFM 22.02%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
ROICexc(3y)7.02%
ROICexc(5y)N/A
ROICexgc(3y)8.91%
ROICexgc(5y)N/A
ROCE(3y)9.19%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1%
ROICexc growth 3YN/A
ROICexc growth 5Y-1.69%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
F-Score8
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Debt/EBITDA 3.35
Cap/Depr 52.23%
Cap/Sales 7.23%
Interest Coverage 4.1
Cash Conversion 100.75%
Profit Quality 276.05%
Current Ratio 0.47
Quick Ratio 0.44
Altman-Z 1.54
F-Score8
WACC5.61%
ROIC/WACC1.48
Cap/Depr(3y)43.12%
Cap/Depr(5y)41.32%
Cap/Sales(3y)6.29%
Cap/Sales(5y)10.19%
Profit Quality(3y)301.12%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
EPS Next Y22.89%
EPS Next 2Y26.59%
EPS Next 3Y21.24%
EPS Next 5Y14.94%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%
Revenue Next Year3.49%
Revenue Next 2Y9.56%
Revenue Next 3Y7.85%
Revenue Next 5Y4.98%
EBIT growth 1Y16.5%
EBIT growth 3YN/A
EBIT growth 5Y-3.89%
EBIT Next Year104.02%
EBIT Next 3Y35.57%
EBIT Next 5Y22.36%
FCF growth 1Y30.27%
FCF growth 3Y19%
FCF growth 5Y6.53%
OCF growth 1Y26.43%
OCF growth 3Y22.57%
OCF growth 5Y1.63%

KINEPOLIS / KIN.BR FAQ

Can you provide the ChartMill fundamental rating for KINEPOLIS?

ChartMill assigns a fundamental rating of 4 / 10 to KIN.BR.


What is the valuation status of KINEPOLIS (KIN.BR) stock?

ChartMill assigns a valuation rating of 7 / 10 to KINEPOLIS (KIN.BR). This can be considered as Undervalued.


What is the profitability of KIN stock?

KINEPOLIS (KIN.BR) has a profitability rating of 5 / 10.


What is the earnings growth outlook for KINEPOLIS?

The Earnings per Share (EPS) of KINEPOLIS (KIN.BR) is expected to grow by 22.89% in the next year.


Can you provide the dividend sustainability for KIN stock?

The dividend rating of KINEPOLIS (KIN.BR) is 3 / 10 and the dividend payout ratio is 31.09%.